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Abstract
Although therapeutic community (TC) treatment is a promising intervention for substance use
disorders, a primary obstacle to successful treatment is premature attrition. Because of their
prevalence within substance use treatment facilities, personality disorder (PD) diagnoses have
been examined as predictors of treatment completion. Prior research on TC outcomes has
focused almost exclusively on antisocial personality disorder (ASPD), and the results have been
mixed. The current study extends previous research by examining the impact of the 10 Axis II
PDs on early (first 30 day) attrition as well as overall time to dropout in a 9-month residential
TC. Survival analyses indicated that borderline was the only PD negatively related to overall
program retention. In contrast, ASPD, as well as histrionic PD, were related to very early
attrition but not to overall program retention. Early assessment and identification of at-risk
individuals may improve treatment retention and outcome for TC treatment.

Keywords: survival; antisocial; borderline; histrionic; SNAP

3
Introduction
Therapeutic community (TC) treatment is a potentially effective psychosocial intervention for
reducing substance use, criminality, unemployment, and other psychosocial problems
experienced by addicted individuals1. Several large-scale studies2-4 have found significant and
sustained improvements following successful completion of a TC typically after 6-12 months of
residential treatment5. These multi-site studies indicate that the most stable predictor of positive
treatment outcomes is retention in the treatment3-9. Unfortunately, it is common in intensive
residential TCs for as many as 50% of residents to drop out within the first month and another
25-40% or more to drop out during subsequent months, often leaving as few as 10% of
admissions who receive a moderately to maximally effective dose of this treatment modality10.
Identification of factors associated with very early attrition and poor longer term retention is
important to help recognize individuals who may be at high risk for poor outcomes and for
whom additional intervention might be necessary.
We evaluated the impact of the 10 Axis II personality disorders (PDs) on very early attrition
(within first 30 days) as well as overall time to dropout during a 9-month treatment program.
PDs are the most common form of co-occurring psychiatric disorder found in TCs11-15 and the
severe and persistent cognitive, emotional, interpersonal, and behavioral problems characterizing
these disorders contribute to poor outcomes in substance abuse treatment as well as a variety of
psychiatric disorders16. Median prevalence rates of Axis II disorders are especially high (7080%) among drug dependent persons treated in inpatient or residential settings17. A systematic
review of the literature18 found that PDs, particularly antisocial (ASPD) and borderline (BPD),
were consistently associated with risks for early drop out from all types of substance abuse
treatment. Other studies19-23 have also documented poor outcomes for PDs in general, including
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their negative association with treatment completion in a large sample of homeless military
veterans in a residential rehabilitation facility24 and among a sample of 307 Norwegian drug
abusers25.
TCs were specifically designed to address the attitude, behavioral, criminogenic, and
personality problems that characterize severe addiction and ASPD. As such, ASPD might be
expected to have no appreciable impact on retention in an effectively run TC. However, studies
evaluating retention among ASPD in TCs have been mixed. Goldstein et al.26 compared patients
who met full criteria for ASPD (i.e., adult criteria and evidence of conduct disorder in childhood)
versus those who only displayed adult antisocial behavior. They found that the ASPD diagnosed
group had poorer retention for the longer (i.e., 180 day) treatment program, but that the groups
did not differ for the 90 day program. In contrast, Haller et al.27 (1997) reported that ASPD was
positively related to treatment retention in a sample of pregnant women. Messina and colleagues
found that ASPD, diagnosed with either self-report inventory28 or semi-structured interview29
was unrelated to several outcome measures, including the completion of the 12 month TC. Most
recently, Daughters et al.30 reported that, while ASPD status did not predict retention on its own,
the interaction of ASPD and court-mandated status did predict early attrition in a sample of 236
male TC patients. Considering these mixed findings for ASPD, continued study of its impact on
TC retention would be helpful in supplementing and potentially clarifying the existing literature.
Although a TC’s highly structured, hierarchical social milieu, emphasizing positive and
negative consequences, may be well suited to ASPD, such an intensive and confrontive peer
pressure environment may not be an effective approach for PDs characterized by significant
cognitive (e.g., paranoid), emotional (e.g., borderline), or interpersonal (e.g., avoidant)
vulnerability or rigidity. We are aware of only a few other studies that have evaluated PDs other
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than ASPD in relation to TC retention. Karterud et al.31 evaluated 97 patients in a Norwegian day
hospital TC and divided the patients into four diagnostic groups: borderline, schizotypal, “other”
PD, and no PD. Borderline and schizotypal groups had greater rates of attrition than did the other
PD or no PD groups. Fals-Stewart32 also examined the MCMI-II 33 PD scales and found that
schizoid and schizotypal scales were negatively related to length of stay within a TC, while
histrionic and narcissistic scales were positively related.
The current study attempted to address several gaps in the literature by conducting a more
thorough evaluation of the relation between all 10 PDs and two measures of retention (i.e., early
attrition, defined as premature dropout within the first 30 days, and overall time to dropout from
the 9-month treatment program). We chose these two frames because of their clinical relevance
and because they corresponded to time frames chosen in prior research. We also addressed the
limitations of previous research31 which relied on unstructured clinical diagnoses, did not test all
PDs, used a general index of retention (percent dropped out), and a lower intensity nonresidential TC milieu. Although previous studies have been mixed, we predicted that ASPD
would not be related to either very early attrition or overall time to dropout. However, we
predicted that borderline PD and several Cluster A (paranoid, schizoid, schizotypal) and Cluster
C (avoidant, obsessive-compulsive) PDs characterized by severe cognitive, emotional, and
interpersonal vulnerabilities would be related to reduced retention.
Method
Participants
We recruited adult and adolescent patients from a long-term residential TC treatment program
for substance abuse located in an urban area in the Northeastern United States. For inclusion,
patients had to be either adolescents (15-18 years; n = 49) or adults (19-65 years; n = 77) and
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have a lifetime DSM-IV substance abuse or dependence diagnosisA. Seven additional patients
provided informed consent, but were excluded based on inability to read or understand the
consent or assessment forms based on the Slosson Oral Reading Test34. Patients with current
suicidal or homicidal plans, severe medical illness, schizophrenia, or bipolar disorder were not
eligible for admission to the residential program. Interested individuals provided consent and
received the baseline packet of self-report materials from a research assistant. Participants
received a $50 store gift card for completing the baseline assessment, $10 for month 1-5
assessments, $60 for the month 6 and $70 for month 9 assessments. This study was approved by
the Institutional Review Board at the authors’ institution.
Materials
Personality disorders were assessed using the Schedule for Nonadaptive and Adaptive
Personality (SNAP) 35. The SNAP is a self-report inventory that includes 375 items rated as true
or false. It provides an assessment of three broad temperaments (i.e., positive affect, negative
affect, and disinhibition) as well as 12 maladaptive trait scales that assess aspects of personality
pathology (e.g., mistrust, aggression, and impulsivity). The SNAP also provides an assessment of
the DSM-III-R36 personality disorders, using some items that overlap with those included in the
trait scales. These PD scales can be scored dimensionally (i.e., summing the items) or can
produce categorical variables for each diagnostic criterion that can then be counted to determine
whether the individual reaches the diagnostic threshold. Scores on the SNAP PD scales obtained
stability coefficients over a nine-month interval ranging from .59 (schizotypal) to .84
(antisocial), with a median of .75 in a non-clinical sample37. SNAP PD scale scores have
demonstrated validity when compared to semi-structured interview measures with a median
convergent correlation of .5535. In addition, SNAP PD scores correlate strongly with scores from
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other self-report PD instruments with a median convergent value of .62 across the 10 PDs38. In
addition, portions of the Structured Clinical Interview for DSM-IV (SCID) were administered for
descriptive purposes.
Procedures
TC residents were approached about their interest in participating in research within one week
of program admission. Eligible and interested residents provided informed consent and
completed a baseline assessment which included the SNAP and then monthly and follow-up
assessments during their participation in a randomized clinical trial of two active
psychotherapies. All participants were admitted to the TC with a minimal length of stay of 9
months and typically by referral through the criminal justice or child protection systems. APT
Residential Services Division embraces most of the core elements that have defined a TC39. The
program involves a highly organized, staff-guided, self-help positive peer pressure process
focused especially on changing attitudes, perceptions and behaviors associated with drug use and
criminality. Peers influence peers to promote learning and assimilation of social norms and
skills. There are strict, explicit, behavioral norms with contingencies to promote self-control and
responsibility. The first 30 days of treatment are spent in a semi-segregated “orientation group
program” in which the rules and responsibilities are learned and residents are supported through
their accommodation to this new milieu. The next 6 or more months are spent in the main TC
program and then followed by 6 or more months in a higher status resident coordinator role or
employment in the community during a re-entry phase.
Although community meetings and psychoeducational groups are important tools, peer
encounter and other therapy groups are considered the core techniques aimed at change. These
groups are meant to heighten each individual’s awareness of specific attitudes or behavioral
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patterns that negatively affect the community and need to be changed for the individual to
recover. All of these groups focus on changing cognitive, behavioral, and emotional processes
that severely impede affiliation with the community and thus prevent socialization and
maturation. In addition, there are an array of professional support services in place (group
counseling, case management, medical care, psychiatric services, educational and vocational
programming). Job or school functions are arranged in a hierarchy according to seniority and
individual productivity such that progress leads to higher levels of management/coordination as
well as additional privileges. This social organization reflects fundamental elements of the
rehabilitative approach: self-help, trust in the community, responsible performance, honesty,
hard work, tough love, and earned successes. These are conceptualized as necessary for longterm recovery from addiction.
Data Analyses
Although the primary result of interest was the impact of PDs on 9-month TC program
retention, attrition in the very early phase of treatment is a significant clinical problem for all
addiction treatment modalities. Therefore, we also chose to evaluate 30 day attrition because the
first month (orientation phase) is a critical phase of adjustment to a TC where separate
programming is provided and because this is the shortest duration used as an outcome variable in
previous TC research. We first conducted univariate analyses using chi-square to evaluate early
drop-out and Kaplan-Meier survival analyses to evaluate days retained in treatment. For these
univariate analyses, each diagnostic group was compared to the group without a PD diagnosis. In
order to evaluate which predictors showed the strongest relationship we then conducted
multivariate analyses by entering all diagnoses simultaneously. Binary logistic regression was
used for early dropout and Cox regression survival analyses for treatment retention. Finally,
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because the field of PD research appears to be moving toward dimensional approaches for DSM540, we repeated the multivariate analyses using dimensional PD scores. For these analyses, the
raw item scores for each SNAP scale were summed to create variables referred to as PD severity
scores. Again, early dropout was evaluated using binary logistic regression and Cox regression
was used for overall retention.
Results
One-hundred and twenty-six participants completed the baseline assessment and 17 (14%)
dropped out before 30 days, and 81 of these participants (64%) did not complete the 9-month
program B. Table 1 provides descriptive statistics on demographic variables as well as selected
Axis I and Axis II PD diagnoses for the entire sample.
Univariate Analyses
We first examined the impact of any PD diagnosis, by comparing those meeting criteria for
one or more PDs (n = 75) to those without any PD diagnosis (n = 51) on both early attrition and
overall time to dropout. Five times as many patients with a PD diagnosis dropped out within the
first 30 days compared to those without a PD diagnosis (see Table 2). Over the entire treatment,
patients with any PD diagnosis completed significantly fewer days in treatment than those
without a PD diagnosis. Chi-square results indicated that antisocial, histrionic, and paranoid PD
diagnoses were significantly related to early attrition. However, when considering overall
number of days in treatment, Kaplan-Meier analyses suggested that borderline, paranoid, and
avoidant diagnoses were significantly predictive of shorter duration over the entire 9 months of
treatment.
Multivariate Analyses
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Seeking to better understand the unique contribution of each individual PD, we then entered
the ten PDs simultaneously into a binary logistic regression predicting the dichotomous variable
of attrition within the first 30 days. Schizotypal diagnosis was excluded from the early attrition
analyses because all 17 individuals meeting criteria for schizotypal remained in treatment at 30
days, providing no variability in the outcome. As with the univariate analyses, ASPD and
histrionic were significantly predictive of early attrition. However, in contrast to the univariate
findings, the impact of a paranoid diagnosis was non-significant when all the diagnoses were
considered simultaneously (see Table 3). Multivariate analyses of days until dropout indicated
that BPD was the only diagnosis that evidenced a significantly shorter stay over the 9-month
treatment. Figure 1 presents the cumulative survival for those with and without a BPD diagnosis.
Dimensional Scores
Finally, in order to determine whether dimensional representations of these constructs would
show comparable findings, we repeated the multivariate analyses using continuous measures of
the PD constructs. A binary logistic regression on the early attrition variable showed that
histrionic severity was significantly predictive of early attrition (Wald χ2 = 5.0, OR = 1.58, 95%
CI = 1.06 – 2.36), while antisocial severity trended but was not significant (Wald χ2 = 3.1, p =
.08; OR = 1.20, 95% CI = .98 – 1.47). Consistent with the categorical results above, a Cox
proportional hazards regression indicated that borderline severity significantly predicted shorter
treatment lengths, Wald χ2 = 4.40, p < .05; H.R. = 1.21, 95% CI = 1.00 – 1.45.
Discussion
Although TCs are a promising treatment modality for severe addiction, criminality,
unemployment, and other psychosocial problems, research has indicated that premature attrition
is negatively associated with these long-term outcomes3. The existing literature has provided
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mixed findings with respect to ASPD and little information about the impact of other PDs on
retention. In contrast with some other research26 our findings replicate those of Messina and
colleagues28-29 who also reported that ASPD was unrelated to TC retention. Globally, the results
of the current study are consistent with previous findings in demonstrating that the presence of
any PD is associated with worse retention in a TC24-25. However, the effect appears to be more
specific both in terms of specific diagnoses and treatment intervals. The current study suggests
that when considered in isolation, individuals with baseline diagnoses of BPD, avoidant, and
paranoid PDs had significantly fewer days in treatment, compared to individuals without a PD
diagnosis. However, when all ten diagnoses were considered simultaneously only BPD remained
significant, suggesting that it is most related to shorter duration, over the course of a 9-month
treatment. Additionally, individuals with ASPD, histrionic, and paranoid PD diagnoses were
significantly more likely than those without any diagnosis to drop out within the first 30 days of
treatment. Nonetheless, multivariate analyses (in which all diagnoses were entered at once)
indicated that only the findings for ASPD and histrionic remained significant. It is perhaps
interesting that, although BPD was the diagnosis with the shortest overall treatment duration, it
was not significantly related to early attrition in the first 30 days.
These findings indicate that individuals with high emotional reactivity (which characterizes
BPD) are not prone to retention problems during the orientation phase of TC treatment when
they are receiving highly structured psychoeducational group and individual meetings focused on
adaptation to the program milieu. During these first 30 days, residents are also relatively
segregated from the broader program population and stressors of peer confrontation and
behavioral consequences. Our results suggest that BPD residents experience retention problems
the longer that they are exposed to the more intensive environment of the regular TC program
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which can be characterized by affectively-charged and interpersonally confrontive interactions
with peers and staff. This type of demanding TC milieu contrasts with existing empirically
supported treatments for BPD such as dialectical behavior therapy41 which focuses explicitly on
balancing change with empathic acceptance and validation of the individual. Research suggests
that this type of treatment can increase retention and treatment outcomes for emotionally
dysregulated and vulnerable patients42-43. Symptoms associated with BPD might not substantially
interfere with the initial orientation to the TC model, but might interfere with the longer-term
effective utilization of the TC’s core treatment processes.
In this sense, the findings for BPD were almost completely opposite those for ASPD and
histrionic as those PDs were both related to early attrition, but not to overall time spent in the
TC. In contrast to BPD, the traits associated with ASPD, such as assertiveness, competitiveness,
and tough-skinned independence, might lead to difficulty accepting the rules and regulations of
the well-controlled environment. However, once the initial orientation period is over, those same
traits might equip the individual for success within (or at least tolerance for) the confrontive TC
atmosphere. The present findings for ASPD at the two time points might also explain its
inconsistent relationship with TC completion in previous studies. The definition of treatment
completion has varied greatly, from as few as 30 days30 to as long as 12 months28. This wide
range of intervals across studies as well as the fact that ASPD might present greater risks early in
treatment suggests that, in addition to programmatic differences across TCs, the previous
research might have been capturing temporal variation.
The finding that histrionic PD is also associated with attrition within the first 30 days of
treatment is somewhat more difficult to understand. Only one other study has examined the
relationship between histrionic PD and TC completion and it suggested that histrionic scores
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were positively related to overall length of treatment32. Nonetheless, that study used a version of
the MCMI33 that researchers have suggested may assess only qualitative, and perhaps even
adaptive, aspects of histrionic PD44. Histrionic is defined primarily by the need to be the center
of attention and represented by traits such as exhibitionism. It is possible that such individuals
also may not respond well to the early phases of TC orientation when they are segregated from
the population and less able to engage the wider attention of all residents and staff. Nonetheless,
the fact that the current study is the first to report that histrionic PD might be related to early TC
attrition should be interpreted cautiously until it can be further tested in additional studies.
While the most robust findings were for BPD (in terms of overall treatment duration) and for
ASPD and histrionic (in terms of attrition within the first 30 days), there were also other PDs that
evidenced an increased risk for attrition. Notably, individuals diagnosed with paranoid PD
completed fewer total days in treatment and were more likely to drop out within the first 30 days
than individuals without a PD diagnosis. In both cases, the findings for paranoid PD were not
significant when considered simultaneously with the other PD diagnoses. This perhaps suggests
that the effect of paranoid might be accounted for by its comorbidity with other disorders, rather
than its unique variance. Similarly, individuals with an avoidant PD diagnosis spent significantly
fewer days in treatment than individuals without any PD diagnoses, but this effect was also not
significant when considered in multivariate analyses. At a minimum these findings suggest that
future studies of premature dropout should also consider paranoid and avoidant PD.
Finally, it is important to note that the present findings were not specific to diagnostic status
defined categorically (i.e., presence vs. absence of the diagnosis) as analyses of dimensional
scorings also obtained comparable results. This is particularly important as it appears
increasingly likely that DSM-5 will incorporate a dimensional understanding of personality
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pathology. Within the currently available proposal40 it appears that ASPD and BPD will continue
to be included (although histrionic might be excluded) but will be rated along a continuum rather
than categorically. If this model is indeed adopted, the dimensional results presented in the
current study might be most relevant to future researchers and clinicians.
Clinical Implications
A primary implication of the current study is the importance of thorough personality
assessment at the outset of treatment within a TC. Specifically, identification of those traits and
behaviors characteristic of BPD and ASPD, as well as perhaps histrionic, paranoid, and avoidant
PDs, is essential as they predicted different retention challenges. The current results suggest that
ASPD should be identified quickly and that specific interventions be targeted toward these
individuals to assist in their engagement and orientation to the TC atmosphere. The findings
suggest that the risk for attrition for these individuals is greatest at the beginning of treatment and
that the personality traits associated with ASPD might have a negligible (or even protective)
effect once they integrate into the TC. Individuals with high standing on BPD, on the other hand,
appear to be at no greater risk for very early attrition in programs that do not require immediate
immersion into the treatment milieu. Nonetheless, the fact that BPD predicted attrition prior to
program completion, suggests that a TC might not be the optimal choice of treatment for these
individuals. Perhaps this initial early period (i.e., first 30 days) can be utilized by identifying the
individuals least likely to benefit from the TC and make programmatic adjustments or external
referral to promote better treatment retention and outcome.
Limitations
The current study provides data on the impact of PDs on TC retention at two different time
points, but is not without limitations. While self-reports of PDs are the most common method of
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assessment within the research literature, semi-structured interviews are considered to be the
most valid method45. In addition, the version of the SNAP employed in the current study assesses
the DSM-III-R categories. Although the differences between the PD scales on the SNAP34 and
the SNAP-246 are relatively minor (typically only a few items were changed), the use of DSM-IV
scales would be preferable. Finally, the initial sample size was larger than some previous
examinations (e.g., 97 patients31 and 65 patients25) but was also smaller than others (e.g., 275
patients28). Nonetheless, the low prevalence of some PDs within this sample perhaps reduced the
ability to detect their impact on retention. This factor, combined with the gender imbalance
typical of most TCs, prevented our evaluation of the effects of gender on retention for all PDs.
Future studies that examine potential gender interactions would be particularly important for
BPD and ASPD given the gender differences in these diagnoses47.
Conclusions
This was the first study to evaluate the categorical and dimensional representation of all 10
PDs in relation to two treatment retention milestones. Our results suggest that previously
inconsistent findings for ASPD might be attributable to the length of the treatment interval used
to define “completion.” Finally, the current study also indicated that BPD negatively relates to
long-term retention suggesting that other treatment modalities or approaches for emotionally
dysregulated individuals might be preferable.
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Footnotes
A

Before combining results from the adolescent and adults, we carefully examined them for

potential differences. Beyond age, t-tests and chi-square analyses did not indicate significant
differences for racial or gender makeup. Significant differences were noted for lifetime substance
diagnoses, with adults more likely to qualify for alcohol, opioid, and stimulant diagnoses while
adolescents were more likely to be diagnosed with cannabis dependence. No differences were
detected for lifetime rates of major depressive disorder or social phobia, but adults were more
likely to have a diagnosis of post-traumatic stress disorder. Most importantly, chi-square
analyses also did not detect significant differences in the diagnostic rate for any of the 10 PDs,
which were the variables of interest in the current study. While diagnosis of PDs within DSM-IV
(APA, 2000) is restricted to individuals over the age of 18, there is increasing evidence for the
continuity of maladaptive personality functioning across this arbitrary threshold49-50.
Additionally, the DSM-5 Personality and Personality Disorders Workgroup proposal40 does not
include an age requirement.
B

Although 270 days represented completion of the formal treatment, some patients remained in

treatment for more than a year.
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Table 1
Descriptive Statistics for Overall Sample on
Demographic Variables, SCID Axis I Diagnoses,
and SNAP Personality Disorder Diagnoses
Overall
(n = 126)
78.6

Variable
Gender (%male)
Race
Caucasian (%)
55.6
African-American (%)
27.6
Hispanic (%)
12.7
other (%)
4.8
Age (M [SD])
26.9 (10.3)
Adult (%)
61.1
Lifetime Substance Diagnosis
Alcohol (%)
69.7
Stimulant (%)
33.6
Opioid (%)
19.7
Cannabis (%)
37.7
other (%)
5.7
Lifetime Axis I Diagnosis
Major Depression (%)
38.5
Social Phobia (%)
22.3
PTSD (%)
20.5
Personality Disorder
Paranoid (%)
20.6
Schizoid (%)
7.1
Schizotypal (%)
13.5
Antisocial (%)
31.0
Borderline (%)
25.4
Histrionic (%)
24.6
Narcissistic (%)
10.3
Avoidant (%)
23.0
Dependent (%)
13.5
Obsessive-Compulsive (%)
3.2
Notes: SCID = Structured Clinical Interview for
DSM-IV- Axis I 48; PTSD = Post-Traumatic Stress
Disorder. SNAP = Schedule for Nonadptive and
Adaptive Personality.
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Table 2
Univariate Analyses for SNAP PD Diagnoses on Early Attrition and Overall Time to Dropout
Early Attrition (< 30 days)
Overall Time to Dropout (270 days)
Diagnostic Group
% Attrited
χ2
p
Mean
95% CI
log-rank χ2
Paranoid (26)
19%
127.1
88.2 - 165.9
4.88
.04
4.27
Schizoid (9)
22%
4.12
.10
141.8
67.9 - 215.7
1.17
Schizotypal (17)
0%
.69
1.00
149.3 104.5 - 194.1
1.25
Antisocial (39)
26%
133.5 100.0 - 167.1
3.25
9.02
.00
Borderline (32)
13%
2.16
.20
114.0
83.4 - 144.7
11.06
Histrionic (31)
26%
141.1 103.9 - 175.7
3.07
8.62
.01
Narcissistic (13)
15%
2.32
.18
126.2
72.3 - 180.0
2.71
Avoidant (29)
14%
2.60
.18
134.4
98.0 - 170.9
4.57
Dependent (17)
18%
3.53
.10
136.9
88.2 - 185.6
1.94
OCPD (4)
25%
3.20
.21
202.8 102.2 - 303.3
.04
Any PD (75)
20%
135.3 112.3 - 158.3
6.72
.02
6.09

p
.04
.28
.26
.07
.00
.08
.10
.03
.16
.85
.01

No PD (51)
4%
191.2 165.8 - 216.5
Notes: Early dropout present chi-square analyses using Fisher's exact test (two-sided). Treatment
completion analyses present results from Kaplan-Meier survival analysis with data right-censored
at 270 days. Each diagnostic group was compared to the group without any PD diagnoses, provided
on the lowest row. SNAP = Schedule for Non-Adaptive and Adaptive Personality (Clark, 1993);
PD = Personality Disorder; Mean = the mean number of days in treatment; CI = Confidence
Interval. Numbers in parentheses indicate the number of patients who met criteria for the PD.
OCPD = Obsessive-Compulsive Personality Disorder. PD = personality disorder. Values in
boldface type indicate significance at p < .05.
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Table 3
Multivariate Analyses of SNAP PD diagnoses on early attrition and overall time to dropout
Overall Time to Dropout (270
days)
Early Dropout (< 30 days)
Wald
χ2
OR
95% CI
Wald χ2
HR
95% CI
2.23
3.49
Paranoid
.68 - 17.96
.38
1.26
.61 - 2.62
1.97
5.26
Schizoid
.52 - 53.44
.10
1.16
.45 - 3.02
.00
Schizotypal
1.36
.58
.23 - 1.45
5.16
5.53
1.31 - 20.22
.04
1.06
.60 - 1.88
Antisocial
1.44
.35
Borderline
.06 - 1.93
1.89
1.05 - 3.40
4.47
5.14
5.35
Histrionic
1.28 - 20.57
.08
1.09
.60 - 1.97
.91
.28
Narcissistic
.02 - 3.76
.23
.79
.29 - 2.11
.78
2.14
Avoidant
.39 - 11.67
1.31
1.45
.77 - 2.72
.07
.80
Dependent
.14 - 4.50
.03
.94
.42 - 2.07
.52
3.57
OCPD
.11 - 112.93
.62
.56
.13 - 2.39
Notes: Early attrition analyses present binary logistic regressions on presence of drop-out at 30
days. Overall time to dropout analyses present Cox regression analyses for attrition over 9months. SNAP = Schedule for Nonadaptive and Adaptive Personality35. PD = Personality
disorder. OR = Odds ratio; HR = Hazard ratio; 95% CI = 95% Confidence Interval. OCPD =
obsessive-compulsive PD. Values in boldface type indicate significance at p < .05. *
Schizotypal was excluded from early attrition analysis due to lack of variability in the outcome
measure.
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Figure 1.
Cox Regression Survival Analysis for Borderline Personality Disorder Diagnosis

Notes: n = 126; BPD = borderline personality disorder; Data right-censored at 270 days.

